CF
RCKT icon

Corebridge Financial’s Rocket Pharmaceuticals RCKT Stock Holding History

Corebridge Financial’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-37,757
Closed -$252K – 2154
2025
Q1 		$252K Buy
37,757
+5,044
+15% +$49.8K ﹤0.01% 1932
2024
Q4 		$411K Sell
32,713
-2,469
-7% -$37.2K ﹤0.01% 1789
2024
Q3 		$650K Sell
35,182
-218
-0.6% -$4.46K ﹤0.01% 1589
2024
Q2 		$762K Buy
+35,400
New +$813K ﹤0.01% 1479

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Corebridge Financial's RCKT Position: Q2 2025 in Review

Corebridge Financial sold out of Rocket Pharmaceuticals (RCKT) in Q2 2025, closing a stake of 37,757 shares — an estimated $252K sold.

Corebridge Financial first reported a position in RCKT in Q2 2024 and held it in 4 quarters. The position peaked at $762K in Q2 2024. 196 funds tracked by Wall St. Rank hold RCKT as of Q2 2025.

  • Corebridge Financial reported no remaining Rocket Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 37,757 Rocket Pharmaceuticals shares in Q2 2025, an estimated $252K.
  • Corebridge Financial first reported a position in Rocket Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Rocket Pharmaceuticals position peaked at $762K in Q2 2024.
  • 196 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.